Surgical Resection in Nontuberculous Mycobacterial Pulmonary Disease

Lauren J Taylor; John D Mitchell

doi:10.1016/j.ccm.2023.06.013

Surgical Resection in Nontuberculous Mycobacterial Pulmonary Disease

Clin Chest Med. 2023 Dec;44(4):861-868. doi: 10.1016/j.ccm.2023.06.013. Epub 2023 Aug 3.

Authors

Lauren J Taylor¹, John D Mitchell²

Affiliations

¹ Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado, 12631 East 17th Avenue, C-310, Aurora, CO 80045, USA.
² General Thoracic Surgery, Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado, 12631 East 17th Avenue, C-310, Aurora, CO 80045, USA. Electronic address: [email protected].

PMID: 37890922
DOI: 10.1016/j.ccm.2023.06.013

Abstract

Rates of nontuberculous mycobacterial pulmonary disease are increasing worldwide, particularly in the United States and other developed countries. While multidrug antimicrobial therapy is the mainstay of treatment, surgical resection has emerged as an important adjunct. In this article, we will review the indications for surgery, preoperative considerations, surgical techniques, and postoperative outcomes.

Keywords: Lung resection; Minimally invasive thoracic surgery; Nontuberculous mycobacteria.

Publication types

Review

MeSH terms

Humans
Lung Diseases* / drug therapy
Lung Diseases* / microbiology
Lung Diseases* / surgery
Mycobacterium Infections, Nontuberculous* / drug therapy
Mycobacterium Infections, Nontuberculous* / microbiology
Mycobacterium Infections, Nontuberculous* / surgery
Nontuberculous Mycobacteria
Pneumonectomy / methods
United States